Fortilab SRL
The score of Fortilab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +4 % Total assets +41 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fortilab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Fortilab's financial analysis
- Solvency14.8%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fortilab
Fortilab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.764.579
- VAT number
- BE0877764579
- Peppol
- Registered · 0208:0877764579 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Dec 2005
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Fortilab (SRL) has been based in Etterbeek since 2005, active in: manufacture of medicaments. For 2025, it reports a net profit of 1,858 € and equity of 205,191 €; its revenue is not published. Its solvency stands at 14.8%, below the median of its sector (41.4%).
Companies similar to Fortilab
Companies in the same business, of comparable size and area, outside its group.
- Vesale Pharma Woman Health Wholesale of pharmaceutical and medical goods Éghezée · balance sheet 62,158 €
- AIP Medical Manufacture of pharmaceutical preparations Olne · balance sheet €1.64m
- Lophar Retail sale of pharmaceutical products Aalter · balance sheet €1.33m
- Feton International Wholesale of pharmaceutical and medical goods La Louvière · balance sheet €1.39m
- Pannoc Chemie Manufacture of pharmaceutical preparations Olen · balance sheet €2.32m
- Hyloris Wholesale of pharmaceutical and medical goods Liège · balance sheet €1.58m
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- Lupumed Wholesale of pharmaceutical and medical goods Ghent · balance sheet €2.08m
Frequently asked questions about Fortilab
What is the revenue of Fortilab?
Fortilab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fortilab?
In Belgium, the VAT number is the company number prefixed with BE: BE0877764579 for Fortilab, if the company is VAT-registered. Its company number (CBE) is 0877.764.579.
Where is the registered office of Fortilab?
According to the CBE register, the registered office of Fortilab is in 1040 Etterbeek.
What is the equity of Fortilab?
At the close of the 2025 financial year, the equity of Fortilab amounts to 205,191 €, a solvency of 14.8% of total assets.
Who manages Fortilab?
The register lists 1 active mandates at Fortilab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Fortilab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →